Literature DB >> 3025289

Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain.

L W Thorpe, K N Westlund, L M Kochersperger, C W Abell, R M Denney.   

Abstract

Monoamine oxidases (MAO; EC 1.4.3.4.) A and B occur in the outer mitochondrial membrane and oxidize a number of important biogenic and xenobiotic amines. Monoclonal antibodies specific for human MAO A or B and immunocytochemical techniques were used to visualize the respective enzymes in human placenta, platelets, lymphocytes, liver, brain, and a human hepatoma cell line. MAO A was observed in the syncytiotrophoblast layer of term placenta, liver, and a subset of neurons in brain, but was not observed in platelets or lymphocytes, which are known to lack type A enzyme. MAO B was observed in platelets, lymphocytes, and liver, but not in placenta, which contains little or no MAO B. MAO B was also observed in a subset of neurons in the brain that was distinct from that which contained MAO A. MAO A and MAO B were also observed in some glia. Unlike most tissues examined, liver cells appeared to contain both forms of the enzyme. These studies show that MAO A and MAO B can be specifically visualized by immunocytochemical means in a variety of human cells and tissues and can provide a graphic demonstration of the high degree of cell specificity of expression of the two forms of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025289     DOI: 10.1177/35.1.3025289

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  24 in total

1.  Mechanistic role for a novel glucocorticoid-KLF11 (TIEG2) protein pathway in stress-induced monoamine oxidase A expression.

Authors:  Matthew Grunewald; Shakevia Johnson; Deyin Lu; Zhe Wang; Gwen Lomberk; Paul R Albert; Craig A Stockmeier; Jeffrey H Meyer; Raul Urrutia; Klaus A Miczek; Mark C Austin; Junming Wang; Ian A Paul; William L Woolverton; Seungmae Seo; Donald B Sittman; Xiao-Ming Ou
Journal:  J Biol Chem       Date:  2012-05-24       Impact factor: 5.157

2.  The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes.

Authors:  B Drukarch; J Flier; C A M Jongenelen; G Andringa; A N M Schoffelmeer
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

3.  cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

Authors:  A W Bach; N C Lan; D L Johnson; C W Abell; M E Bembenek; S W Kwan; P H Seeburg; J C Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  R1, a novel repressor of the human monoamine oxidase A.

Authors:  Kevin Chen; Xiao-Ming Ou; Gao Chen; Si Ho Choi; Jean C Shih
Journal:  J Biol Chem       Date:  2005-01-14       Impact factor: 5.157

5.  Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2011-04-04       Impact factor: 3.922

6.  Human monoamine oxidase A gene determines levels of enzyme activity.

Authors:  G S Hotamisligil; X O Breakefield
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

Review 7.  Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management.

Authors:  Mohamed Naguib; Robert Koorn
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 8.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

9.  Norrie disease gene is distinct from the monoamine oxidase genes.

Authors:  K B Sims; L Ozelius; T Corey; W B Rinehart; R Liberfarb; J Haines; W J Chen; R Norio; E Sankila; A de la Chapelle
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

10.  Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretrovirals.

Authors:  Walter Rangel Lopes de Campos; Dayaneethie Coopusamy; Lynn Morris; Bongani M Mayosi; Makobetsa Khati
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.